Literature DB >> 167710

Multiple cyclic nucleotide phosphodiesterase activities from rat tissues and occurrence of a calcium-plus-magnesium-ion-dependent phosphodiesterase and its protein activator.

S Kakiuchi, R Yamazaki, Y Teshima, K Uenishi, E Miyamoto.   

Abstract

1. Supernatant fluids from rat cerebral cortex, cerebellum, kidney, heart and liver contained more phosphodiesterase activity hydrolysing cyclic GMP than that hydrolysing cyclic AMP when assayed with sub-saturating concentrations of substrate. 2. These activities were resolved into several fractions by Sephadex G-200 gel filtration; no two tissues had similar activity profiles. 3. With every tissue examined, a fraction (fraction II) with a molecular weight of about 150,000 was obtained which hydrolysed cyclic GMP preferentially at sub-saturating substrate concentrations in the presence of micromolar concentration of Ca2+, millimolar concentration of Mg2+ and a protein activator. 4. The activity of fraction II accounted for about 60 percent in liver, more than 80 percent in heart and cerebellum, and almost 100 percent in cerebral cortex of the total activity for cyclic GMP hydrolysis, calculated from the activity profiles. 5. Km values of fraction II samples from kidney, heart and liver for cyclic GMP were 1.3, 1.7 and 5 muM respectively. 6. 3-Isobutyl-1-methylxanthine inhibited hydrolysis of cyclic GMP by fraction II with an I50 value of 3muM for heart and liver and 50 muM for cerebrum. 7. The activator protein, with an estimated molecular weight of about 30,000 was isolated from all the tissues listed in 1.8. The concentrations of activator protein and of the isolated enzyme, fraction II, did not correspond exactly.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167710      PMCID: PMC1165280          DOI: 10.1042/bj1460109

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  The role of calcium in the superprecipitation of actomyosin.

Authors:  A WEBER; S WINICUR
Journal:  J Biol Chem       Date:  1961-12       Impact factor: 5.157

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Hydrolysis of cyclic guanosine and adenosine 3',5'-monophosphates by rat and bovine tissues.

Authors:  J A Beavo; J G Hardman; E W Sutherland
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

4.  Preparation and properties of a cyclic 3',5'-nucleotide phosphodiesterase isolated from frog erythrocytes.

Authors:  O M Rosen
Journal:  Arch Biochem Biophys       Date:  1970-04       Impact factor: 4.013

5.  Cyclic 3',5'-nucleotide phosphodiesterase. Demonstration of an activator.

Authors:  W Y Cheung
Journal:  Biochem Biophys Res Commun       Date:  1970-02-06       Impact factor: 3.575

6.  Adenosine 3'5'-monophosphate phosphodiesterase: multiple molecular forms.

Authors:  E Monn; R O Christiansen
Journal:  Science       Date:  1971-08-06       Impact factor: 47.728

7.  The assay of adenosine 3',5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate in biological materials by enzymatic radioisotopic displacement.

Authors:  G Brooker; L J Thomas; M M Appleman
Journal:  Biochemistry       Date:  1968-12       Impact factor: 3.162

8.  Cyclic 3',5'-nucleotide phosphodiesterase. A continous titrimetric assay.

Authors:  W Y Cheung
Journal:  Anal Biochem       Date:  1969-04-04       Impact factor: 3.365

Review 9.  Cyclic GMP.

Authors:  N D Goldberg; R F O'Dea; M K Haddox
Journal:  Adv Cyclic Nucleotide Res       Date:  1973

10.  Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine.

Authors:  R W BUTCHER; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

View more
  20 in total

1.  Translocation of neural modulators a second category of nerve signal.

Authors:  H McIlwain
Journal:  Neurochem Res       Date:  1976-08       Impact factor: 3.996

2.  Electron-microscopic cytochemical study of cyclic nucleotide phosphodiesterase in rat brain.

Authors:  K Sugimura; A Mizutani
Journal:  Histochemistry       Date:  1978-03-02

3.  Calcium-dependent regulator protein: localization in mitotic apparatus of eukaryotic cells.

Authors:  M J Welsh; J R Dedman; B R Brinkley; A R Means
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

4.  The effect of K-252a, a potent microbial inhibitor of protein kinase, on activated cyclic nucleotide phosphodiesterase.

Authors:  Y Matsuda; S Nakanishi; K Nagasawa; K Iwahashi; H Kase
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

5.  Cyclic AMP phosphodiesterase activity during differentiation of rabbit erythroid bone marrow cells.

Authors:  M S Setchenska; H R Arnstein; J G Vassileva-Popova
Journal:  Biochem J       Date:  1981-06-15       Impact factor: 3.857

Review 6.  Calmodulin.

Authors:  Y M Lin
Journal:  Mol Cell Biochem       Date:  1982-06-11       Impact factor: 3.396

7.  Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines.

Authors:  J W Daly; P Butts-Lamb; W Padgett
Journal:  Cell Mol Neurobiol       Date:  1983-03       Impact factor: 5.046

8.  Differential effects of methylxanthines on local cerebral blood flow and glucose utilization in the conscious rat.

Authors:  J J Grome; V Stefanovich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-06       Impact factor: 3.000

9.  Characterization of calmodulin-dependent cyclic nucleotide phosphodiesterase isoenzymes.

Authors:  R K Sharma; J Kalra
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

10.  Inhibitory effect of calcium-binding protein regucalcin on Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase activity in rat liver cytosol.

Authors:  M Yamaguchi; H Tai
Journal:  Mol Cell Biochem       Date:  1991-07-24       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.